Indraprastha Medical Corporation Ltd

INDRAMEDCO

Watchlist

AI Mode

‌

Market Cap

₹ 4,478 Cr

P/E

25.63

‌

‌
‌

‌

‌
‌

Investment Checklist

How to read checklist?

Performance

MARKET LEADER

Valuation

REASONABLE

Growth

STABLE

Profitability

HIGH MARGIN

Technicals

Bearish

Risk

MODERATE RISK

Investment Checklist

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

Price

PE Ratio

Price

‌

Overview

Detailed Summary

Indraprastha Medical Corporation Limited provides high-quality, comprehensive hospital services, enhancing patients' quality of life.

The company has established India's first corporate hospital, a multi-disciplinary super-speciality tertiary care hospital in New Delhi.

Recent advancements include robotic surgeries, complex transplants, and unique procedures like 3D-assisted surgeries and innovative cancer treatments.

The hospital continues to innovate, highlighted by breakthroughs like the first robotic hip replacement in North India and Zap-X radiosurgery.

A strong focus on infrastructure enhancements and patient experience is evident, with several new clinical services and significant technology investments.

Sector

Healthcare

Industry

Hospitals / Medical Services

Market Cap

4,478 Cr

Volatility

High Risk

P/E Ratio

25.6

Industry P/E

62.6

PEG Ratio

3.2

P/B Ratio

6.8

52W High

640.05

52W Low

307.90

Sales CAGR

8.97%

15.16%

10.30%

10Y

6.72%

Profit CAGR

29.87%

40.04%

29.84%

10Y

23.31%

ROE

TTM

26.54%

25.52%

21.05%

10Y

17.71%

ROCE

TTM

34.84%

31.05%

25.82%

10Y

22.40%

Technicals

‌

Forecasts

No. of Analysts

7

1Y Price Target

703.80 ▲ 43.99%

Q3 EPS Estimate

Q3 Revenue Estimate

Unlock Premium Features

Price, EPS and Revenue Projections

Strong SellSellHoldBuyStrong Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

updated on

Dec 03, 2025

Peers

Symbol	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
YATHARTH	698.45	6,717 Cr	44.04	3.98	0.00	9.03	11.86	8.22
KOVAI	6025.00	6,571 Cr	28.75	5.52	0.17	19.21	21.31	11.92
INDRAMEDCO	488.45	4,478 Cr	25.63	6.80	0.92	26.54	34.84	18.31
ARTEMISMED	280.95	4,453 Cr	46.91	3.89	0.14	10.76	13.34	6.64
DRAGARWQ	5470.00	2,637 Cr	41.87	8.38	0.11	20.02	14.77	8.64
SHALBY	195.50	2,107 Cr	475.85	2.10	0.00	0.45	6.06	-0.01
KMCSHIL	75.44	1,230 Cr	40.56	6.75	0.00	16.69	19.54	10.15

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

AI Mode

Standalone Quarterly Results (in ₹ Crores)

Total Figures

QoQ Changes

Total Figures

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Sales	307	317	306	315	348	350	325	334	365	381
Expenses	259	267	259	266	281	286	273	272	292	310
Operating Profit	47	50	47	48	67	64	52	61	73	71
OPM %	15.42	15.89	15.43	15.39	19.30	18.19	16.06	18.37	20.04	18.72
Other Income	3.56	4.17	4.27	4.89	5.12	6.05	5.13	6.35	6.90	7.37
Interest	0.78	0.85	0.87	1.56	1.61	1.59	1.58	1.49	1.56	1.51
Depreciation	9.81	10	10	10	11	11	11	11	10	11
Profit Before Tax	40	44	41	42	60	57	45	55	68	66
Tax %	24.19	24.74	27.61	25.00	24.87	25.52	26.32	25.80	24.67	25.41
Net Profit	31	33	29	31	45	42	33	41	51	49
EPS in Rs	3.33	3.58	3.21	3.40	4.88	4.63	3.58	4.47	5.61	5.40

Standalone Profit Loss (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	766	753	788	831	613	888	1,099	1,245	1,356	1,374
Expenses	687	680	707	744	573	774	948	1,051	1,112	1,123
Operating Profit	79	73	81	86	40	114	151	193	244	250
OPM %	10.29	9.67	10.25	10.40	6.57	12.87	13.72	15.53	18.01	18.22
Other Income	0.46	0.79	0.47	0.69	0.68	3.12	10	17	23	24
Interest	7.91	8.90	6.87	5.92	3.34	3.41	4.28	4.06	6.27	6.22
Depreciation	31	31	30	33	33	35	39	40	44	43
Profit Before Tax	41	34	45	48	4.29	79	117	166	216	225
Tax %	35.70	37.94	36.32	9.48	45.69	25.86	26.48	25.37	25.58	25.49
Net Profit	26	21	28	44	2.33	59	86	124	161	168
EPS in Rs	2.85	2.30	3.11	4.76	0.28	6.40	9.39	13.52	17.56	19.06
Dividend Payout %	62.94	65.22	51.61	0.00	0.00	39.12	31.91	33.28	25.63	—

Standalone Balance Sheet (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	92	92	92	92	92	92	92	92	92	92
Reserves	132	139	141	152	176	181	234	288	386	505
Borrowings	47	65	60	15	3.98	2.51	5.31	2.48	34	33
Other Liabilities	190	163	140	163	177	157	131	173	212	222
Total Liabilities	460	458	432	422	449	432	462	555	723	852
Fixed Assets	301	296	294	280	303	283	277	275	347	328
CWIP	2.60	0.00	0.00	1.26	0.00	3.33	0.00	2.53	0.47	33
Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Assets	157	163	138	141	146	145	185	278	376	491
Total Assets	460	458	432	422	449	432	462	555	723	852

Standalone Cash Flows (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	62	28	48	75	86	27	94	144	200	157
Cash from Investing Activity	-33	-22	-30	-17	-40	-19	-74	-108	-158	-111
Cash from Financing Activity	-30	-5.39	-17	-44	-43	-3.14	-3.37	-26	-32	-46
Net Cash Flow	-0.46	-0.15	0.58	14	3.51	4.59	17	11	9.34	-0.12

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Promoters	51.00%	51.00%	51.00%	51.00%	51.00%	51.00%	51.00%	51.00%	51.00%	51.00%	51.00%	51.00%
FIIs	0.77%	0.27%	0.37%	0.80%	0.95%	1.08%	1.70%	2.64%	2.88%	2.94%	2.72%	2.41%
DIIs	0.00%	0.00%	0.00%	6.71%	6.37%	4.91%	3.15%	3.20%	3.19%	3.56%	3.56%	3.51%
Public	48.22%	48.72%	48.62%	41.49%	41.68%	43.01%	44.15%	43.16%	42.93%	42.51%	42.72%	43.08%
Total Shareholders	52,760	49,833	48,630	47,865	51,448	54,158	55,103	64,671	69,697	70,491	70,211	70,914

Market Transactions

Date	Party	Category	Type	Avg Price (₹)	Total Value (₹)	Quantity	Percent Traded
Oct 08, 2025	Graviton research capital llp	Bulk	Buy	587.07	72.38 Cr	12,32,834	1.34
Oct 08, 2025	Graviton research capital llp	Bulk	Sell	586.98	72.34 Cr	12,32,350	1.34
Oct 07, 2025	Sway financial services	Bulk	Buy	555.26	27.08 Cr	4,87,634	0.53
Oct 07, 2025	Sway financial services	Bulk	Sell	512.53	0.48 Cr	9,294	0.01
Apr 22, 2024	Quant mutual fund - quant sma...	Bulk	Buy	249.59	13.73 Cr	5,50,000	0.59

Projection

Unlock Premium Features

Get In-depth insights on EPS and Revenue forecasts

Actions

Action Type

‌
‌

Announcements

Last 7 days

Newest

Sentiment

Sorry, no results found!

Documents

Presentations

Concalls

Reports

Presentations

No documents found!

AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.

AI Mode

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

AI Mode

Standalone Quarterly Results (in ₹ Crores)

Total Figures

QoQ Changes

Total Figures

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Sales	307	317	306	315	348	350	325	334	365	381
Expenses	259	267	259	266	281	286	273	272	292	310
Operating Profit	47	50	47	48	67	64	52	61	73	71
OPM %	15.42	15.89	15.43	15.39	19.30	18.19	16.06	18.37	20.04	18.72
Other Income	3.56	4.17	4.27	4.89	5.12	6.05	5.13	6.35	6.90	7.37
Interest	0.78	0.85	0.87	1.56	1.61	1.59	1.58	1.49	1.56	1.51
Depreciation	9.81	10	10	10	11	11	11	11	10	11
Profit Before Tax	40	44	41	42	60	57	45	55	68	66
Tax %	24.19	24.74	27.61	25.00	24.87	25.52	26.32	25.80	24.67	25.41
Net Profit	31	33	29	31	45	42	33	41	51	49
EPS in Rs	3.33	3.58	3.21	3.40	4.88	4.63	3.58	4.47	5.61	5.40

Standalone Profit Loss (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	766	753	788	831	613	888	1,099	1,245	1,356	1,374
Expenses	687	680	707	744	573	774	948	1,051	1,112	1,123
Operating Profit	79	73	81	86	40	114	151	193	244	250
OPM %	10.29	9.67	10.25	10.40	6.57	12.87	13.72	15.53	18.01	18.22
Other Income	0.46	0.79	0.47	0.69	0.68	3.12	10	17	23	24
Interest	7.91	8.90	6.87	5.92	3.34	3.41	4.28	4.06	6.27	6.22
Depreciation	31	31	30	33	33	35	39	40	44	43
Profit Before Tax	41	34	45	48	4.29	79	117	166	216	225
Tax %	35.70	37.94	36.32	9.48	45.69	25.86	26.48	25.37	25.58	25.49
Net Profit	26	21	28	44	2.33	59	86	124	161	168
EPS in Rs	2.85	2.30	3.11	4.76	0.28	6.40	9.39	13.52	17.56	19.06
Dividend Payout %	62.94	65.22	51.61	0.00	0.00	39.12	31.91	33.28	25.63	—

Standalone Balance Sheet (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	92	92	92	92	92	92	92	92	92	92
Reserves	132	139	141	152	176	181	234	288	386	505
Borrowings	47	65	60	15	3.98	2.51	5.31	2.48	34	33
Other Liabilities	190	163	140	163	177	157	131	173	212	222
Total Liabilities	460	458	432	422	449	432	462	555	723	852
Fixed Assets	301	296	294	280	303	283	277	275	347	328
CWIP	2.60	0.00	0.00	1.26	0.00	3.33	0.00	2.53	0.47	33
Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Assets	157	163	138	141	146	145	185	278	376	491
Total Assets	460	458	432	422	449	432	462	555	723	852

Standalone Cash Flows (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	62	28	48	75	86	27	94	144	200	157
Cash from Investing Activity	-33	-22	-30	-17	-40	-19	-74	-108	-158	-111
Cash from Financing Activity	-30	-5.39	-17	-44	-43	-3.14	-3.37	-26	-32	-46
Net Cash Flow	-0.46	-0.15	0.58	14	3.51	4.59	17	11	9.34	-0.12

Oscillators

BearishNeutralBullish

Bullish

Bearish

Neutral

Bullish

Overall

BearishNeutralBullish

Bearish

Neutral

Bullish

Moving Averages

BearishNeutralBullish

Bearish

Neutral

Bullish

Overall

BearishNeutralBullish

Bearish

Neutral

Bullish

Peers

Symbol	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
YATHARTH	698.45	6,717 Cr	44.04	3.98	0.00	9.03	11.86	8.22
KOVAI	6025.00	6,571 Cr	28.75	5.52	0.17	19.21	21.31	11.92
INDRAMEDCO	488.45	4,478 Cr	25.63	6.80	0.92	26.54	34.84	18.31
ARTEMISMED	280.95	4,453 Cr	46.91	3.89	0.14	10.76	13.34	6.64
DRAGARWQ	5470.00	2,637 Cr	41.87	8.38	0.11	20.02	14.77	8.64
SHALBY	195.50	2,107 Cr	475.85	2.10	0.00	0.45	6.06	-0.01
KMCSHIL	75.44	1,230 Cr	40.56	6.75	0.00	16.69	19.54	10.15

Overview

Detailed Summary

Indraprastha Medical Corporation Limited provides high-quality, comprehensive hospital services, enhancing patients' quality of life.

The company has established India's first corporate hospital, a multi-disciplinary super-speciality tertiary care hospital in New Delhi.

Recent advancements include robotic surgeries, complex transplants, and unique procedures like 3D-assisted surgeries and innovative cancer treatments.

The hospital continues to innovate, highlighted by breakthroughs like the first robotic hip replacement in North India and Zap-X radiosurgery.

A strong focus on infrastructure enhancements and patient experience is evident, with several new clinical services and significant technology investments.

Sector

Healthcare

Industry

Hospitals / Medical Services

Market Cap

4,478 Cr

Volatility

High Risk

P/E Ratio

25.6

Industry P/E

62.6

PEG Ratio

3.2

P/B Ratio

6.8

52W High

640.05

52W Low

307.90

Sales CAGR

8.97%

15.16%

10.30%

10Y

6.72%

Profit CAGR

29.87%

40.04%

29.84%

10Y

23.31%

ROE

TTM

26.54%

25.52%

21.05%

10Y

17.71%

ROCE

TTM

34.84%

31.05%

25.82%

10Y

22.40%